1Oh D, Shin S Y, Kang J H, et al. NMR structural characterization of cecropin A ( 1-8 ) - magainin 2 ( 1-12 ) and cecropin A ( 1-8 ) -melit- tin(1-12) hybrid peptides[Jl. J Pept Res,1999,53(5):578- 589.
2Doyle J, Brinkworth C S,Wegener K L, et al. nNOS inhibition, an- timicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications-The solution structure of a modified citropin 1. 1 [ J]. Eur J Biochem,2003,270( 11 ) : 1141- 1153.
3Dennisona S R,Harrisb F, Phoenix D A. The interactions of aurein 1.2 with cancer cell membranes[ J]. Biol Chem ,2007,127 ( 1-2 ) : 78 -83.
4Mader J S,Smyth D, Marshall J S, et al. Bovine lactoferricin inhib- its basic fibroblast growth factor and vascular endothelial growth factorl65-induced angiogenesis by competing for heparinqike bind- ing sites on endothelial cells [ J ]. Pathol, 2006, 169 ( 5 ) : 1753- 1766.
6Ohsaki Y, Gazdar A F, Chen H C. Antitumor activity of magainin analogues against human cancer cell lines [ J ]. Cancer Res, 1992, 52(13) :3534-3538.
7Lincke C R, van der Bliek A M, Schuurhuis G J, et al. Muhidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdrl complementary DNA [ J ]. Cancer Res, 1990,50 (6) : 1779-1785.
8Hui L,Leung K, Chen H M. The combined effects of antibacterial peptide cecropinA and anti-cancer agents on leukemia cells [ J ]. Anticancer Res, 2002,22 ( 5 ) : 2811-2816.
8Hiemstra PS, Ferule-King BA, McMichael J, et al. Antimicrobial peptide : mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics [ J]. Curt Pharm Des, 2004, 10 (23) :2891 - 2905.
9Nijnik A, Madera L, Ma S, et al. Synthetic cationic pep-tide IDR-1002 provides protection against bacterial infectionsthrough chemokine induc- tion and enhanced leukocyte recruitment [ J]. J Immunol,2010,184 (5) : 2539 -2550.
10Ueno S, Kusaka K, Tamada Y, et al. An enhancer peptide for membrane- disrupting antimicrobial peptides[ J ]. BMC Microbio1,2010 ,10 :46.
